Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots and blue light emergency communication systems, has received an order for three of its K1 Blue Light Emergency Phones from a southern Florida university. The order was placed through Transportation Solutions & Lighting, a Florida-based reseller of Knightscope technologies that previously ordered 40 K1 Blue Light Towers in order to supply growing demand for emergency communications solutions.
A compact version of the familiar blue-light towers often found in parking lots and campuses across the United States, KSCP’s K1 Blue Light Emergency Phone offering is a perfect way to provide added security and safety in areas with limited space. The phones feature one-touch connectivity and a high-visibility blue strobe in areas that tower designs may not be viable.
In addition, KSCP noted that Orange County Convention Center (“OCCC”) is hosting a media day to introduce its recent addition to the center’s security force: a Knightscope Autonomous Security Robot (“ASR”). The first convention center to deploy a KSCP ASR, the facility noted that the robot will play a vital role in ensuring the safety of OCCC guests by increasing the scope of surveillance on the center’s campus. The media day is scheduled for Friday, March 24, 2023, and will include a demonstration model of the ASR.
To view the full press release, visit https://ibn.fm/Mvzf4
About Knightscope, Inc.
Knightscope is an advanced security technology company based in Silicon Valley that builds fully autonomous security robots that deter, detect and report. The company’s long-term ambition is to make the United States of America the safest country in the world. For more information about the company, please visit www.Knightscope.com.
NOTE TO INVESTORS: The latest news and updates relating to KSCP are available in the company’s newsroom at https://ibn.fm/KSCP
About TinyGems
TinyGems is your guide to the best and brightest in the under-appreciated small-cap sector. As one of 50+ brands within the InvestorBrandNetwork (“IBN”), TinyGems provides: (1) access to a network of wire solutions via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible; (2) article and editorial syndication to 5,000+ news outlets; (3) enhanced press release solutions to ensure maximum impact; (4) social media distribution via IBN to reach millions of social media followers; and (5) a full array of corporate communications solutions. It’s time to uncover some of the best-kept secrets on Wall Street. TinyGems features innovative small-cap companies with huge potential, putting a spotlight on the best and brightest of these disruptors that have the technology, the talent, the drive, and the business models to make a huge impact in the markets and in portfolios. Whether it’s a game changing technology, a new more profitable product or service, or a star in a hot sector, TinyGems is the go-to source for actionable intelligence.
To receive SMS text alerts from TinyGems, text “Gems” to 888-902-4192 (U.S. Mobile Phones Only)
For more information, please visit https://www.TinyGems.com
Please see full terms of use and disclaimers on the TinyGems website applicable to all content provided by TinyGems, wherever published or re-published: https://www.TinyGems.com/Disclaimer
TinyGems
Los Angeles, California
www.TinyGems.com
310.299.1717 Office
Editor@TinyGems.com
TinyGems is part of the InvestorBrandNetwork.
Disseminated on behalf of SolarBank Corporation SolarBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2), a…
Calidi Biotherapeutics (NYSE American: CLDI) announced FDA clearance of its Investigational New Drug application for CLD-201,…
NextPlat (NASDAQ: NXPL, NXPLW), a global e-commerce provider, announced that its subsidiary, Global Telesat Communications…
Mullen Automotive (NASDAQ: MULN), an electric vehicle manufacturer, announced the sale of its all-electric Mullen…
NextPlat (NASDAQ: NXPL, NXPLW), a global e-commerce provider, announced it will pause select initiatives within…
Calidi Biotherapeutics (NYSE American: CLDI) has named Dr. Guy Travis Clifton as Chief Medical Officer,…